LAXMIDENTL
Laxmi Dental Limited manufactures and sells dental products in India, the United States, the United Kingdom, and internationally. It offers custom-made crowns, bridges, clear aligners, thermoforming sheets, and aligner related products, and pediatric dental products. The company serves dental clinics, dental companies, and dentist. The company was incorporated in 2004 and is based in Mumbai, Indi… Read more
LAXMIDENTL (LAXMIDENTL) - Net Assets
Latest net assets as of March 2025: ₹2.09 Billion INR
Based on the latest financial reports, LAXMIDENTL (LAXMIDENTL) has net assets worth ₹2.09 Billion INR as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹2.85 Billion) and total liabilities (₹759.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹2.09 Billion |
| % of Total Assets | 73.31% |
| Annual Growth Rate | 108.71% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 158.1 |
LAXMIDENTL - Net Assets Trend (2022–2025)
This chart illustrates how LAXMIDENTL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for LAXMIDENTL (2022–2025)
The table below shows the annual net assets of LAXMIDENTL from 2022 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹2.09 Billion | +368.23% |
| 2024-03-31 | ₹445.72 Million | +128.79% |
| 2023-03-31 | ₹194.82 Million | -15.09% |
| 2022-03-31 | ₹229.44 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to LAXMIDENTL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 44999000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₹2.09 Billion | 100.00% |
| Total Equity | ₹2.09 Billion | 100.00% |
LAXMIDENTL Competitors by Market Cap
The table below lists competitors of LAXMIDENTL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Savezone I&C Corp.
KQ:067830
|
$18.92K |
|
Astro Communications Inc
PINK:ASTO
|
$18.93K |
|
WCM BETEILIGUNG - Dusseldorf Stock Exchang
DU:WCMK
|
$18.93K |
|
STANBIC HOLDINGS PLC
XNAI:CFC
|
$18.95K |
|
ASHMORE GRP
BE:A1B
|
$18.91K |
|
Shinsung Solar Energy Co. Ltd.
KQ:011930
|
$18.90K |
|
Wojas SA
WAR:WOJ
|
$18.90K |
|
TEO LT (ZWS.SG)
STU:ZWS
|
$18.90K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LAXMIDENTL's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 424,650,000 to 2,085,370,000, a change of 1,660,720,000 (391.1%).
- Net income of 317,710,000 contributed positively to equity growth.
- New share issuances of 1,380,000,000 increased equity.
- Other factors decreased equity by 36,990,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹317.71 Million | +15.24% |
| Share Issuances | ₹1.38 Billion | +66.18% |
| Other Changes | ₹-36.99 Million | -1.77% |
| Total Change | ₹- | 391.08% |
Book Value vs Market Value Analysis
This analysis compares LAXMIDENTL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.55x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 45.01x to 4.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-03-31 | ₹3.83 | ₹172.49 | x |
| 2023-03-31 | ₹3.24 | ₹172.49 | x |
| 2024-03-31 | ₹7.73 | ₹172.49 | x |
| 2025-03-31 | ₹37.94 | ₹172.49 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LAXMIDENTL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.24%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.43%
- • Asset Turnover: 0.83x
- • Equity Multiplier: 1.37x
- Recent ROE (15.24%) is above the historical average (-8.98%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -87.18% | -14.18% | 1.26x | 4.88x | ₹-204.72 Million |
| 2023 | -22.33% | -2.50% | 1.65x | 5.43x | ₹-57.52 Million |
| 2024 | 58.35% | 12.94% | 1.42x | 3.17x | ₹205.31 Million |
| 2025 | 15.24% | 13.43% | 0.83x | 1.37x | ₹109.17 Million |
Industry Comparison
This section compares LAXMIDENTL's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $3,922,527,667
- Average return on equity (ROE) among peers: 20.20%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LAXMIDENTL (LAXMIDENTL) | ₹2.09 Billion | -87.18% | 0.36x | $18.92K |
| AGARWALEYE (AGARWALEYE) | $6.59 Billion | 14.28% | 1.77x | $295.11 Million |
| Poly Medicure Limited (POLYMED) | $278.57 Million | 25.76% | 1.06x | $481.09 Million |
| Tarsons Products Limited (TARSONS) | $4.90 Billion | 20.55% | 0.11x | $22.74 Million |